Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis
CONCLUSIONS: Reported rates of genetic testing for people with ovarian cancer remain well below the goal of universal testing. Interventions such as mainstreaming can improve testing uptake. Strategies aimed at improving utilization of genetic services should consider existing disparities in race and insurance status.PMID:34023131 | DOI:10.1016/j.ygyno.2021.05.011
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Jenny Lin Ravi N Sharaf Rachel Saganty Danyal Ahsan Julia Feit Andrea Khoury Hannah Bergeron Eloise Chapman-Davis Evelyn Cantillo Kevin Holcomb Stephanie V Blank Ying Liu Charlene Thomas Paul J Christos Drew N Wright Steven Lipkin Kenneth Offit Melissa K Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Insurance | Ovarian Cancer | Ovaries | Reflex Sympathetic Dystrophy | Study | Women